• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

13.58 +1.78 (+15.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
News headline image
Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗
October 21, 2022
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 18, 2022 ↗
October 18, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 17, 2022 ↗
October 17, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52 
Via Benzinga
News headline image
Psyched: VC Fund Invests $50M In Psychedelics, Musk's 'Exploratory Journeys', Native American Use Of Peyote And More ↗
October 14, 2022
Palo Santo Closes $50M Investment Fund Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million... 
Via Benzinga
News headline image
Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
October 14, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From October 12, 2022 ↗
October 12, 2022
GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48 
Via Benzinga
News headline image
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression ↗
October 12, 2022
Psychedelics biotech company Compass Pathways (NASDAQ: CMPS) announced it will conduct two separate Phase 3 clinical trials to study psilocybin-assisted therapy on Treatment-Resistant Depression... 
Via Benzinga
News headline image
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today ↗
October 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12 
Via Benzinga
News headline image
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial... 
Via PressReach
News headline image
Psychedelic Stock Gainers And Losers From October 10, 2022 ↗
October 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS: 
Via Benzinga
News headline image
Psychedelic Drug Stocks Index Up Slightly This Week ↗
October 08, 2022
There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From October 6, 2022 ↗
October 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22 
Via Benzinga
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
October 04, 2022
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
October 03, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58 
Via Benzinga
News headline image
September Cannabis Category Performances Ranged From -6.3% To -39.0% ↗
October 03, 2022
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September... 
Via Talk Markets
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
September 30, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
September 29, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 28, 2022 ↗
September 28, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16 
Via Benzinga
News headline image
Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗
September 27, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10 
Via Benzinga
News headline image
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
September 26, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13 
Via Benzinga
News headline image
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: How Are They Commercialized? ↗
September 26, 2022
(Part four of a four-part series) 
Via Benzinga
News headline image
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗
September 25, 2022
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From September 22, 2022 ↗
September 22, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
News headline image
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying ↗
September 22, 2022
(Part three of a four-part series) Despite ongoing legal setbacks, psychedelics research has reemerged and it is proving that psilocybin reduces brain connections within the usual networks while... 
Via Benzinga
News headline image
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From September 21, 2022 ↗
September 21, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
News headline image
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
September 20, 2022
GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 19, 2022 ↗
September 19, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.28% at $0.65 
Via Benzinga
News headline image
The 5 Cannabis Categories Declined Between 3% And 11.5% Last Week ↗
September 19, 2022
The cannabis sector consists of 5 distinctly different categories and they each perform quite differently. 
Via Talk Markets
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap